Kunming Longjin Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 41.370 million compared to CNY 65.213 million a year ago. Operating loss was CNY 4.728 million compared to operating Income of CNY 7.101 million a year ago. Net loss was CNY 4.189 million compared to net income of CNY 5.237 million a year ago. Basic loss per share from continuing operations was CNY 0.0105 compared to basic earnings per share from continuing operations of CNY 0.0131 a year ago.